NEW

PatientRightsAdvocate.org (PRA) has released its Seventh Semi-Annual Hospital Price Transparency Report, revealing a significant…

The United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) recently sent an Untitled Letter…

Earlier this year, the United States Food and Drug Administration (FDA) issued a draft guidance, “Addressing Misinformation About…

The Senate Health, Education, Labor and Pensions (HELP) Committee voted unanimously to advance two resolutions – one civil and one…

This week on the Policy and Medicine Podcast, we unpack a range of timely and impactful stories that highlight critical changes…

The Substance Abuse and Mental Health Services Administration (SAMHSA) has recently released a comprehensive updates to the…

The US Food and Drug Administration (FDA) has published reports on communications and guidance documents as mandated by Congress…

In a recent win for health care providers, the United States Court of Appeals for the Fifth Circuit affirmed a lower court’s…

The Minnesota Department of Health recently unveiled a pivotal report on the 340B drug pricing program, which provides insight…

The Policy and Medicine Podcast is back with its latest episode for December 1, 2024, offering in-depth discussions and analysis…